VENICE, ITALY – Set in the romantic city of Venice from October 17th to 19th, the 10th World Congress on Targeting Microbiota is set to convene. This worldwide gathering of researchers, clinicians, and industry professionals will offer a dynamic platform for in-depth discussions, latest research insights, and groundbreaking developments in the fascinating world of microbiota.
Credit: International Society of Microbiota (ISM)
VENICE, ITALY – Set in the romantic city of Venice from October 17th to 19th, the 10th World Congress on Targeting Microbiota is set to convene. This worldwide gathering of researchers, clinicians, and industry professionals will offer a dynamic platform for in-depth discussions, latest research insights, and groundbreaking developments in the fascinating world of microbiota.
Targeting Microbiota 2023: What’s New?
The congress will focus on breakthrough research and the latest developments in microbiotal medicine, exploring its implications for human health and well-being. The sessions will provide insights into the strategies and barriers in harnessing microbiota’s power for future medical treatments, the role of microbiota in diseases, and the influence of environment and lifestyle on the microbiota.
Key sessions include:
Microbiota & The Medicine of Tomorrow: Strategies and Barriers – An exploration of the innovative approaches to leverage the potential of microbiotal medicine.
Targeting Microbiota in Diseases: Preventative & Therapeutic Strategies – A focus on the role of microbiota in various diseases, and the latest advancements in microbiota-based interventions.
Environment, Lifestyle & Microbiota: A “One Health” Approach – Highlighting the interconnectedness of human health and the environment and the impact of lifestyle choices on microbiota.
ISM 2023 Innovations
A special session is dedicated to the latest breakthroughs, technological advancements, and novel discoveries in microbiota research. The congress invites researchers and companies to present their innovations, fostering collaboration and inspiring new possibilities in microbiotal medicine.
Targeting Microbiota 2023 Speaker Lineup
Peter C. Konturek, President of ISM, Teaching Hospital of the University of Jena, Germany – COVID 19 and Microbiota – A Story with a Long Tail
Maria Cecilia Giron, University of Padova, Italy – Microbiota & Myelinazation: The Latest Findings
Marvin Edeas, Founder & Chairman of ISM’s Committee, Institut Cochin, INSERM, Université de Paris, France – Microbiota, Prophages & Phage Therapy: The Missing Link
Markus Egert, Furtwangen University, Germany – Domestic Cleaning and Human Microbiome – Is There a Link?
Michael Silverman, University of Pennsylvania, USA – Arresting microbiome development limits immune system maturation and resistance to infection in mice
Cammie Lesser, Harvard University, USA – Engineered Escherichia Coli for the in Situ Secretion of Therapeutic Nanobodies in the Gut
Karl-Herbert Schäfer, Kaiserlautern University of Applied Sciences, Germany – Microbiota and Interactions with the Enteric Nervous System
Pamela Tozzo, University of Padova, Italy – Skin Microbial Changes during Space Flights
Ramakrishna Kommagani, Baylor College of Medicine, USA – Gut Microbiota & Microbiota-Derived Metabolites Role in Endometriosis
Birgitte Moen, Nofima, Norway – Mapping the Kitchen Microbiota in Five European Countries
Joshua Lyte, United States Department of Agriculture, Agricultural Research Service, USA – Environmental Drivers of Avian Enteric Neuroendocrine Plasticity in the Context of Foodborne Pathogen Carriage
Roberta Raffaetà, Università Ca’ Foscari Venezia, Italy – Anthropology and Research on the Microbiome: Addressing Future Health
Matthew Chang, National University of Singapore, Singapore – Microbiome Engineering: Reprograming microbes to rewire host-microbiome interactions
Vincenzo Di Pilato, University of Genoa, Italy – Evaluation of Transitional Changes Shaping the Infants’ Gut Microbiota in Early Life: The CI.EMME Study
Lena Öhman, University of Gothenburg, Sweden – Fecal Gut Microbiota and Metabolite Signatures as Biomarkers for Gastrointestinal Disorders
Andrew Y. Koh, University of Texas Southwestern Medical Center, USA – Gut Microbiota and Cancer Immunotherapy
Francis K L Chan, The Chinese University of Hong Kong, China – Clinical Applications of Gut Microbiota: Gut Microbiome for Prediction of Colorectal Neoplasia
Souhaila Al Khodor, Sidra Medicine, Qatar – Multi-omics in Colon Cancer and Role of the Microbiome
Yu Chen, The 7th Affiliated Hospital of Southern Medical University, China – Effect of Gut Microbiota Regulation on Non-Alcoholic Fatty Liver Disease
Valentina Caputi, United States Department of Agriculture, Agricultural Research Service, USA – Microbiota, Enteric Nervous and Immune Systems: Barrier Defenses against Foodborne Pathogens Carriage in Poultry
For more information about the congress, including registration details, visit the official congress website: www.microbiota-site.com.
About the International Society of Microbiota (ISM)
The ISM was established in 2013, evolving from the Task Force Mitochondria-Microbiota to encompass experts in the field of microbiota. The ISM aims to accelerate the credible translation of microbiota science into real benefits for consumers. It also encourages communication and interaction among researchers, physicians, nutritionists, industry professionals, and strategic marketing managers through a global microbiota network, particularly during its annual world meeting.
For media inquiries, please contact: [email protected].
